Clinical Trials in Villejuif, Paris
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled294 locationsNCT06926868
Recruiting
Phase 1
Study of STP938 in Advanced Solid Tumours
Solid Tumor
Step Pharma, SAS70 enrolled7 locationsNCT06297525
Recruiting
Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Carcinoma, Non-Small Cell LungGastroesophageal Junction AdenocarcinomaStomach Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer914 enrolled44 locationsNCT06131840
Recruiting
Phase 1Phase 2
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Relapsed/Refractory Non-Hodgkin Lymphoma
Bristol-Myers Squibb308 enrolled65 locationsNCT06090539
Recruiting
Phase 1Phase 2
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
Advanced Solid TumorNSCLC
Ellipses Pharma265 enrolled40 locationsNCT05443126
Recruiting
Phase 1Phase 2
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Bristol-Myers Squibb413 enrolled21 locationsNCT06697197